Press Coverage

Drugmaker Chugai’s stock surges 60% to rival Sony’s value on hopes for virus treatment

Excerpt: Chugai’s Shimizu declined to comment on the surge in its share price ahead of a three-for-one stock split effective on July 1.Others point to the nature of markets themselves, with Travis Lundy, an analyst who publishes at SmartKarma, pointing to the …

Gearoid Reidy, Ayaka Maki • (Opens in a new window) ⧉

Are you a Professional Journalist?

The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.


Request your Press Pass Now